A Patient Videoconference on Inhibitors & New Novel Therapies – Answering Your Questions!


On November 2, 2020, the CHS held a live educational videoconference aimed to improve the understanding of FVIII/FIX inhibitors and treatment options, with a special focus on emicizumab. The topics of the webinar included the following:

  • Introduction to inhibitor development – who and why? (Dr. Georges-Étienne Rivard)
  • How patients with inhibitors have been historically managed and what has changed (Dr. Manuel Carcao)
  • Emicizumab – what is it and what do studies tell us about its effectiveness and safety (Dr. Jerry Teitel)
  • Practical aspects of being on emicizumab (Vanessa Bouskill, MN, RN[EC])
  • How to manage bleeds and surgery when on emicizumab (Dr. Jean St-Louis)
  • The future of immune tolerance induction (ITI) therapy and bypassing agent (FEIBA/rFVIIa) (Dr. Manuel Carcao)